Innovative Solutions & Support Reports Third Quarter 2024 Results
Contacts IR CONTACT Paul Bartolai or Noel Ryan ISSC@val-adv.com Innovative Solutions & Support, Inc. (Nasdaq: ISSC) ("IS&S" or the "Company"),...
PR News
Disc Medicine Reports Second Quarter 2024 Financial Results and Provides Business Update
WATERTOWN, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,...
Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
– Initiation of Phase 1 CALiPSO-1 Trial of CNTY-101 in Systemic Lupus Erythematosus, marking strategic expansion into autoimmune disease; protocol...
ChipMOS REPORTS 12.4% YoY GROWTH IN JULY 2024 REVENUE, UP 7.6% MoM
HSINCHU, Aug. 9, 2024 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 andNasdaq: IMOS), an industry...
Ingles Markets, Incorporated Reports Results for Third Quarter and First Nine Months of Fiscal 2024
ContactsIngles Markets, Inc. Pat Jackson, Chief Financial Officer pjackson@ingles-markets.com (828) 669-2941 (Ext. 223) Ingles Markets, Incorporated (NASDAQ: IMKTA) today reported...
iHeartMedia, Inc. Reports Results for 2024 Second Quarter
Contacts Media Wendy Goldberg Chief Communications Officer (212) 377-1105 wendygoldberg@iheartmedia.com Investors Mike McGuinness EVP, Deputy CFO, and Head of Investor...
InflaRx Reports Second Quarter 2024 Financial Results and Provides Business Update
JENA, Germany, Aug. 08, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today...
Hudson Global Reports 2024 Second Quarter Results
OLD GREENWICH, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (Nasdaq: HSON) ("Hudson Global" or "the Company"), a...
HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024The company is exploring the potential for...
Harvard Bioscience Announces Second Quarter 2024 Financial Results
HOLLISTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for...
Gyre Therapeutics to Present at Sidoti Virtual Investor Conference
SAN DIEGO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical...
Gravity Reports Second Quarter of 2024 Results and Business Update
Seoul, South Korea, Aug. 09, 2024 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and...
Golden Matrix Group to Announce Second Quarter Financial Results on August 13th
LAS VEGAS, NV, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Golden Matrix Group Inc. (NASDAQ: GMGI), a developer and licensor of...
Gain Therapeutics Reports Financial Results for Second Quarter 2024 and Provides Corporate Update
Topline Results From MAD Phase 1 Study of GT-02287 on Track for August 2024 With Full Presentation at Upcoming Medical...
Liberty Media Corporation Reports Second Quarter 2024 Financial Results
Contacts Shane Kleinstein (720) 875-5432 Liberty Media Corporation (“Liberty Media” or “Liberty”) (NASDAQ: LSXMA, LSXMB, LSXMK, FWONA, FWONK, LLYVA, LLYVK)...
Liberty Media Corporation Reports Second Quarter 2024 Financial Results
Contacts Shane Kleinstein (720) 875-5432 Liberty Media Corporation (“Liberty Media” or “Liberty”) (NASDAQ: LSXMA, LSXMB, LSXMK, FWONA, FWONK, LLYVA, LLYVK)...
Shareholders of Five Below, Inc. Should Contact Levi & Korsinsky Before September 30, 2024 to Discuss Your Rights – FIVE
NEW YORK, Aug. 9, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Five Below, Inc. ("FIVE" or the...
Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate Update
ATLANTA, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet...
Extreme Networks Announces Investor Conference Schedule for August and September 2024
Contacts Investor Relations and Press Contacts: Stan Kovler Vice President, Corporate Strategy & Investor Relations Extreme Networks 919-595-4196 skovler@extremenetworks.com Amy...
Edgewise Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
– Completed Phase 1 SAD and MAD trial of EDG-7500 in healthy volunteers; Dosing patients in Phase 2 CIRRUS-HCM trial...
Evergy Announces Second Quarter 2024 Results, Declares Quarterly Dividend and Reaffirms 2024 Guidance
Second Quarter 2024 GAAP EPS of $0.90, compared to $0.78 in 2023 Second Quarter 2024 Adjusted EPS (Non-GAAP) of $0.90,...
Evoke Pharma, Inc. Supports Gastroparesis Awareness Month
Collaborating with advocacy groups to amplify gastroparesis awareness for millions of patients worldwideCall for action to improve health and access...
Evaxion to Present One-Year Clinical Efficacy Data from its Phase 2 Study on Lead Cancer Vaccine Candidate, EVX-01, at the ESMO Congress 2024 in September
COPENHAGEN, Denmark, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in...
Enphase Energy Introduces NACS Connectors for IQ EV Chargers in the United States and Canada
FREMONT, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the...
Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results
PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care...
Smart Share Global Limited Announces Receipt of Minimum Bid Price Notice from Nasdaq
SHANGHAI, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer...
EuroDry Ltd. Reports Results for the Six-Month Period and Quarter Ended June 30, 2024
ATHENS, Greece, Aug. 08, 2024 (GLOBE NEWSWIRE) -- EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator...
electroCore to Participate in Upcoming Investor Conferences
ROCKAWAY, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced...
Precision BioSciences Announces Investigational New Drug Clearance by Partner TG Therapeutics for Investigation of Azer-Cel for Multiple Sclerosis
- Out licensed allogeneic CAR T azer-cel receives IND clearance from U.S. FDA Contacts Investor Contact: Naresh Tanna Vice President,...
SAP Enterprise Cloud Services Selects CyberArk to Safeguard the World’s Largest Organizations
Contacts Investor Relations: Srinivas Anantha, CFA CyberArk 617-558-2132 ir@cyberark.com Media: Nick Bowman CyberArk +44 (0) 7841 673378 press@cyberark.com CyberArk (NASDAQ:...
Cronos Group Reports 2024 Second Quarter Results
Net revenue in Q2 2024 increased by 46% year-over-year to $27.8 millionIndustry-leading balance sheet with $848 million in cash and...
Crinetics Launches ACRO/TRUTH Educational Initiative to Raise Awareness of Acromegaly Treatment Challenges
SAN DIEGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the launch of the ACRO/TRUTH...
Creative Media & Community Trust Corporation Reports 2024 Second Quarter Results
Contacts For Creative Media & Community Trust Corporation Media Relations: Bill Mendel, 212-397-1030 bill@mendelcommunications.com or Shareholder Relations: Steve Altebrando, 646-652-8473...
Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
ALPHARETTA, Ga., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies...
Calumet Reports Second Quarter 2024 Results
INDIANAPOLIS, Aug. 9, 2024 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) today reported results of Calumet Specialty Products Partners, L.P. (the...
Central Garden & Pet to Participate in the Barclays 17th Annual Global Consumer Staples Conference
Contacts Investor Relations Contact Friederike Edelmann VP Investor Relations & Corporate Sustainability (925) 412-6726 fedelmann@central.com Central Garden & Pet Company...
Central Garden & Pet to Participate in the Barclays 17th Annual Global Consumer Staples Conference
Contacts Investor Relations Contact Friederike Edelmann VP Investor Relations & Corporate Sustainability (925) 412-6726 fedelmann@central.com Central Garden & Pet Company...
CBAK Energy Reports Second Quarter and First Half 2024 Unaudited Financial Results
DALIAN, China, Aug. 9, 2024 /PRNewswire/ -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) ("CBAK Energy," or the "Company") a leading...
Berry Corporation Reports Second Quarter 2024 Financial and Operating Results
DALLAS, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) announced second quarter 2024...
Barinthus Bio Reports Second Quarter 2024 Update on Corporate Developments and Financial Results
OXFORD, United Kingdom, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), a clinical-stage biopharmaceutical company developing novel...